| View |
|
DRP-804-04
|
Prednisolone Acetate
|
PredCare
|
10 mg/mL (1% w/v)
|
Ophthalmic Suspension
|
Corticosteroid
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
02 November 2023
|
19 February 2028
|
| View |
|
DRP-8746-05
|
Cefuroxime (as sodium)
|
Cefumac
|
1. 5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
02 November 2023
|
20 February 2025
|
| View |
|
DRP-9124-08
|
Lactulose
|
Consilose
|
3 .33g / 5 mL
|
Oral Solution
|
Laxative
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 November 2023
|
04 September 2025
|
| View |
|
DRP-9124-09
|
Lactulose
|
Lactera
|
3.33g / 5 mL
|
Oral Solution
|
Laxative
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 November 2023
|
04 September 2025
|
| View |
|
DRP-9181-01
|
Cefuroxime (as sodium)
|
None
|
1.5 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 November 2023
|
30 September 2025
|
| View |
|
DRP-9445-01
|
Phytomenadione
|
Vitaden K
|
10 mg / mL
|
Solution for Injection (IM/IV/SC)
|
Hemostatic
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 November 2023
|
09 January 2025
|
| View |
|
DRP-9664-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Ureitaz
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 November 2023
|
27 April 2026
|
| View |
|
DRP-9885-14
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
02 November 2023
|
25 January 2026
|
| View |
|
DRP-XY43721
|
Olanzapine
|
Olavex 10
|
10 mg
|
Tablet
|
Antipsychotic
|
AKUMS DRUGS & PHARMACEUTCALS LTD
|
India
|
Automatic Renewal
|
06 November 2023
|
12 September 2029
|
| View |
|
DRP-13253
|
Dextromethorphan Hydrobromide + Guaifenesin
|
Syguadex
|
15 mg/100 mg per 5 mL
|
Syrup
|
Antitussive/Expectorant
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
11 January 2023
|
11 January 2028
|
| View |
|
DRP-14663
|
Oxytocin
|
Oxycore
|
10 I.U./mL
|
Solution for Injection (I.V./I.M./S.C.)
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Initial
|
17 November 2023
|
17 November 2028
|
| View |
|
DRP-14685
|
Iodixanol
|
Cardiolek-320
|
652 mg/mL Solution for Injection (equivalent to 320 mg
Iodine)
|
Solution for Injection
|
-
|
Unique Pharmaceutical Laboratories (A Division of J.B Chemicals & Pharmaceuticals Ltd.)
|
India
|
Initial
|
24 November 2023
|
24 November 2028
|
| View |
|
DRP-14684
|
Hyoscine Butylbromide
|
Hyovin
|
20 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Divine Laboratories Pvt. Ltd.
|
India
|
Initial
|
24 November 2023
|
24 November 2028
|
| View |
|
DRP-14664
|
Hyoscine Butylbromide
|
Hyosur
|
20 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Kwality Pharmaceuticals Ltd.
|
India
|
Initial
|
21 November 2023
|
21 November 2028
|
| View |
|
DRP-14687
|
Losartan Potassium + Amlodipine (as besilate)
|
Losastal-A 110
|
100 mg/10 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
23 November 2023
|
23 November 2028
|
| View |
|
DRP-14686
|
Losartan Potassium + Amlodipine (as besilate)
|
Losastal-A 105
|
100 mg/5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
23 November 2023
|
23 November 2028
|
| View |
|
DRP-14668
|
Miconazole nitrate
|
Fungigen
|
20 mg (2% w/w) per g
|
Cream
|
Antifungal for Topical use (Imidazole and triazole
derivatives)
|
Galentic Pharma India Pvt. Ltd.
|
India
|
Initial [OTC][Correction]
|
16 January 2024
|
22 November 2028
|
| View |
|
DRHR-2312
|
Ethyl Alcohol
|
Biogenic
|
70% Solution
|
Solution For External Use
|
-
|
Cosmetique Asia Corporation
|
Philippines
|
Initial [OTC]
|
17 November 2023
|
17 November 2028
|
| View |
|
DR-XY48921
|
Benzydamine Hydrochloride + Chlorhexidine Digluconate
|
Solmux Throat
|
1.5mg/1.2 mg per mL
|
Oromucosal Spray
|
-
|
Humanis Sağlık Anonim Şirketi
|
Turkey
|
nitial [OTC]
|
17 November 2023
|
17 November 2028
|
| View |
|
DR-XY48923
|
Benzydamine
Digluconate
Hydrochloride + Chlorhexidine
|
Swifteze
|
1.5 mg/1.2 mg per mL
|
Oromucosal Spray
|
-
|
Humanis Sağlık Anonim Şirketi
|
Turkey
|
Initial [OTC]
|
17 November 2023
|
17 November 2028
|